Immunoconjugates in cervical cancer: a bibliometric and thematic mapping analysis of global research trends, 2015–2024
Frontiers in Oncology · 23.04.2026 · 16
DOI: 10.3389/fonc.2026.1732209 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Oncology, online erschienen am 23.04.2026. Verfasst von Xiaodong Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, China. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Immunoconjugates, particularly antibody drug conjugates, are emerging as clinically relevant options for recurrent or metastatic cervical cancer. A quantitative overview of how this field has evolved over the last decade remains limited.
Methods
Publications from 2015–2024 were retrieved from the Web of Science Core Collection and Scopus, restricted to English articles and reviews, de-duplicated, and screened by two reviewers, yielding 244 records for analysis. Bibliometric indicators were calculated using bibliometrix in R, while VOSviewer and CiteSpace were used for keyword co-occurrence mapping and burst detection, respectively.
Results
Output increased markedly after 2021, consistent with a shift toward clinical translation. Keyword mapping identified five interlinked themes spanning clinical safety and toxicity management, hematologic malignancy related translational influences, preclinical mechanisms, gynecologic oncology applications, and clinical trial design with emerging therapeutics. Burst analysis indicated a temporal transition from early model based and mechanistic terms to clinically oriented hotspots, including tissue factor and immunotherapy associated concepts.
Conclusions
The literature depicts rapid maturation of immunoconjugate research in cervical cancer from foundational studies toward clinically actionable targets, safety optimization, and combination strategies, providing a roadmap for prioritizing future translational efforts.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, China.
- Department of General Medicine, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, China.
- Department of Orthopaedic Surgery, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, China.
Zitieren
APA
Wang, X., Xiong, D., Cui, S., Duan, B., Ding, G., Huang, Y., & Wang, Q. (2026). Immunoconjugates in cervical cancer: a bibliometric and thematic mapping analysis of global research trends, 2015–2024. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1732209
Vancouver
Wang X, Xiong D, Cui S, Duan B, Ding G, Huang Y, et al. Immunoconjugates in cervical cancer: a bibliometric and thematic mapping analysis of global research trends, 2015–2024. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1732209
BibTeX
@article{Wang2026,
author = {Wang, Xiaodong and Xiong, Di and Cui, Songli and Duan, Bingchen and Ding, Gouping and Huang, Yiping and Wang, Qianqian},
title = {Immunoconjugates in cervical cancer: a bibliometric and thematic mapping analysis of global research trends, 2015–2024},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1732209}
}
EUVIMED